Terms: = Gastric cancer AND MYH11, ENSG00000133392, 4629 AND Prognosis
3 results:
1. Histone deacetylase-mediated tumor microenvironment characteristics and synergistic immunotherapy in gastric cancer.
Lin Y; Jing X; Chen Z; Pan X; Xu D; Yu X; Zhong F; Zhao L; Yang C; Wang B; Wang S; Ye Y; Shen Z
Theranostics; 2023; 13(13):4574-4600. PubMed ID: 37649598
[No Abstract] [Full Text] [Related]
2. Interaction between DNMT3B and myh11 via hypermethylation regulates gastric cancer progression.
Wang J; Xu P; Hao Y; Yu T; Liu L; Song Y; Li Y
BMC Cancer; 2021 Aug; 21(1):914. PubMed ID: 34380460
[TBL] [Abstract] [Full Text] [Related]
3. Validating the prognostic and discriminating value of the TNM-classification for gastric cancer - a critical appraisal.
Röcken C; Behrens HM
Eur J Cancer; 2015 Mar; 51(5):577-86. PubMed ID: 25682192
[TBL] [Abstract] [Full Text] [Related]
